On the other hand, in a model of early-stage AD induced by intrahippocampal injection of okadaic acid, which enhances the activity of the Tau kinase GSK-3β and increases Tau phosphorylation, the level of TRH increases in the brain, as does the level of TRH in the blood serum [266]. The gene discussed is TRH; the disease is Alzheimer disease.